Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation
- 1. Biological Research Laboratories, Daiichi Sankyo Co. Ltd., Tokyo 134-8630 (Japan)
- 2. Translational Medicine and Clinical Pharmacology Department, Daiichi Sankyo Co. Ltd., Tokyo 134-8630 (Japan)
Description
Highlights: → Siglec-15 was identified as a gene overexpressed in giant cell tumor. → Siglec-15 mRNA expression increased in association with osteoclast differentiation. → Polyclonal antibody to Siglec-15 inhibited osteoclast differentiation in vitro. -- Abstract: Osteoclasts are tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells derived from monocyte/macrophage-lineage precursors and are critically responsible for bone resorption. In giant cell tumor of bone (GCT), numerous TRAP-positive multinucleated giant cells emerge and severe osteolytic bone destruction occurs, implying that the emerged giant cells are biologically similar to osteoclasts. To identify novel genes involved in osteoclastogenesis, we searched genes whose expression pattern was significantly different in GCT from normal and other bone tumor tissues. By screening a human gene expression database, we identified sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) as one of the genes markedly overexpressed in GCT. The mRNA expression level of Siglec-15 increased in association with osteoclast differentiation in cultures of mouse primary unfractionated bone marrow cells (UBMC), RAW264.7 cells of the mouse macrophage cell line and human osteoclast precursors (OCP). Treatment with polyclonal antibody to mouse Siglec-15 markedly inhibited osteoclast differentiation in primary mouse bone marrow monocyte/macrophage (BMM) cells stimulated with receptor activator of nuclear factor κB ligand (RANKL) or tumor necrosis factor (TNF)-α. The antibody also inhibited osteoclast differentiation in cultures of mouse UBMC and RAW264.7 cells stimulated with active vitamin D3 and RANKL, respectively. Finally, treatment with polyclonal antibody to human Siglec-15 inhibited RANKL-induced TRAP-positive multinuclear cell formation in a human OCP culture. These results suggest that Siglec-15 plays an important role in osteoclast differentiation.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2011.05.015Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2011.05.015;
- PII
- S0006-291X(11)00768-6;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 409
- Journal Issue
- 3
- Journal Page Range
- p. 424-429
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45025854
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ACID PHOSPHATASE; ANTIBODIES; BONE MARROW; BONE MARROW CELLS; GENES; IMMUNOGLOBULINS; IN VITRO; LIGANDS; MACROPHAGES; MESSENGER-RNA; MICE; MONOCYTES; NEOPLASMS; PRECURSOR; RECEPTORS; SIALIC ACID; SKELETON; TUMOR CELLS; VITAMIN D
- Descriptors DEC
- ANIMAL CELLS; ANIMAL TISSUES; ANIMALS; BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY; BODY FLUIDS; CONNECTIVE TISSUE CELLS; DISEASES; ENZYMES; ESTERASES; GLOBULINS; HEMATOPOIETIC SYSTEM; HYDROLASES; LEUKOCYTES; MAMMALS; MATERIALS; MEMBRANE PROTEINS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; PHAGOCYTES; PHOSPHATASES; PROTEINS; RNA; RODENTS; SOMATIC CELLS; VERTEBRATES; VITAMINS
Optional Information
- Copyright
- Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.